Xsolis Names Lee Rivas as New CEO
The appointment of a new CEO at Xsolis signals a shift in leadership for the Franklin-based health technology firm.
Updated on Oct. 27, 2026 in People
Live Poll
Does new executive leadership usually improve how healthcare technology companies serve patients and providers?
Xsolis has appointed Lee Rivas as its new Chief Executive Officer, succeeding Joan Butters, who led the firm from 2013 to 2026. Rivas brings executive experience from his prior leadership roles at Cloudmed and R1 RCM.
Why it matters
The transition marks a shift in leadership for the Franklin-based health technology firm after 13 years of growth under Butters. Operators should monitor how Rivas pivots or maintains the company's strategic direction given his background in healthcare data and revenue cycle management.
Joan Butters led Xsolis for 13 years prior to this transition, while the new CEO Lee Rivas spent 14 years at RELX. The appointment marks a shift in executive leadership for the Franklin company.
The players
Lee Rivas
The new Chief Executive Officer of Xsolis who previously served as CEO of Cloudmed and R1 RCM.
Joan Butters
The outgoing CEO of Xsolis who steered the company for 13 years since 2013.
Xsolis
A health technology firm based in Franklin, Tennessee, focused on data-driven solutions for healthcare operations.
The details
Rivas steps into the role with extensive experience in the healthcare technology sector, including tenures as CEO of both R1 RCM and Cloudmed. His background also includes a 14-year period at RELX, a data and analytics firm. Rivas is a graduate of the United States Military Academy and holds an MBA from Harvard Business School.
Timeline
2013: Joan Butters began leading Xsolis.
October 27, 2026: Lee Rivas officially assumed the role of CEO.
Market Landscape
This transition follows the 13-year leadership tenure established by Joan Butters starting in 2013. The appointment reflects a broader trend of firms recruiting executives with deep experience in healthcare data analytics and revenue cycle management to scale operations.
Operators in the healthcare technology space should track whether the new leadership shifts focus toward the specific revenue cycle analytics that define the current market. Keep an eye on incoming product roadmaps and strategic partnerships as the firm enters this new chapter.
The takeaway
Leadership changes at established firms often signal a shift in priorities or a push for new market expansion. Monitor future product announcements or company statements for signals on how Rivas intends to scale the business following this transition.
Further reading
For more on executive shifts, visit our section on People.
More information
For more information on the company, visit the company website.
Source note: This article includes information reported by The Manila times.
Live Poll
Does new executive leadership usually improve how healthcare technology companies serve patients and providers?
